JoVE Logo
Centre de ressources universitaires

S'identifier

Whole-Body Nanoparticle Aerosol Inhalation Exposures

DOI :

10.3791/50263-v

May 7th, 2013

May 7th, 2013

15,545 Views

1Department of Physiology and Pharmacology, School of Medicine, West Virginia University , 2Center for Cardiovascular and Respiratory Sciences, West Virginia University , 3National Institute for Occupational Safety and Health

A whole-body nanoparticle aerosol inhalation exposure facility was constructed for nano-sized titanium dioxide (TiO2) inhalation toxicology studies. This system provides nano-TiO2 aerosol test atmospheres that have: 1) a steady mass concentration; 2) a homogenous composition free of contaminants; and 3) a stable particle size distribution during aerosol generation.

-- Vues

Vidéos Connexes

article

Measuring Respiratory Function in Mice Using Unrestrained Whole-body Plethysmography

article

Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae

article

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

article

Design and Development of Aptamer–Gold Nanoparticle Based Colorimetric Assays for In-the-field Applications

article

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing

article

Dosimetry for Cell Irradiation using Orthovoltage (40-300 kV) X-Ray Facilities

article

Construction of a Realistic, Whole-Body, Three-Dimensional Equine Skeletal Model using Computed Tomography Data

article

Nanoparticle Tracking Analysis for the Quantification and Size Determination of Extracellular Vesicles

article

An Antimicrobial Fabric Using Nano-Herbal Encapsulation of Essential Oils

article

Direct Synthesis of EM-Visible Gold Nanoparticles in Cells for Protein Localization Analysis with Well-Preserved Ultrastructure

JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2024 MyJoVE Corporation. Tous droits réservés.